Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000984817 | SCV001132698 | likely pathogenic | not provided | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001062521 | SCV001227328 | pathogenic | Deafness-lymphedema-leukemia syndrome; Monocytopenia with susceptibility to infections | 2019-06-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in GATA2 are known to be pathogenic (PMID: 21670465, 23223431). This variant has not been reported in the literature in individuals with GATA2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg343*) in the GATA2 gene. It is expected to result in an absent or disrupted protein product. |